Omega-3 Triglyceride Fish Oil 1100 mg

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements4.8 (2,951 ratings)
Format:Softgel Quantity: 120 Softgel(s) · 120 servings
Goals
$44.95 $0.37 per serving

Product analysis

62 out of 100

Omega-3 Triglyceride Fish Oil 1100 mg supplies EPA and DHA for heart-related nutrition and offers good value for these active fats.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The precise forms of the listed fats are not clearly disclosed. That limits a confident comparison of their quality and absorption.

Ingredient Transparency70

The amounts and relevant component details are stated, making the active fats easier to distinguish from total oil weight. The precise forms remain unspecified.

Value For Money92

Value is favorable for the EPA and combined EPA and DHA supplied. DHA on its own offers more moderate value.

Customer Satisfaction89

Customer feedback is very positive across a substantial review history. Reviews support the pattern of satisfaction without proving health benefits.

Product Focus68

The clearest role is heart-related nutrition through EPA and DHA. The wider range of skin, eye, joint and focus aims has more mixed or limited support.

Format
Softgel
Container
120 Softgel(s)
Per serving
$0.37
Customer rating
4.8 · 2,951 ratings
Report analysis

Goals

Impact
Highest effect
B Ingredient FitC- PathwaysA+ EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 729 mg
Study evidence
Cardiovascular Support
Impact
High effect
B Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Fish Oil · 1326 mg
Study evidence
Fish Oil Supportive 185 studies
Inflammation
Impact
Moderate effect
C+ Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Fish Oil · 1326 mg
Study evidence
Fish Oil Supportive 68 studies
Impact
High effect
B Ingredient FitC PathwaysB EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 729 mg
Study evidence
Metabolism Support
Impact
Moderate effect
D+ Ingredient FitD- PathwaysA- EvidenceA+ Formulation Logic
Omega-3 · 96 mg
Study evidence
Omega-3 Supportive 42 studies
Joint Health
Impact
High effect
B- Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Omega-3 · 96 mg
Study evidence
Omega-3 Supportive 40 studies

Ingredients

IngredientAmount per servingScore
Calories
15 Calorie(s)
Calories from Fat
10 Calorie(s)
Total Fat
1.5 Gram(s)
Molecularly distilled Fish Oil
1326 mg 87
Total Omega-3 Fatty Acids
1100 mg 78
Eicosapentaenoic Acid
729 mg 86
Docosahexaenoic Acid
275 mg 77
Other Omega-3 Fatty Acids
96 mg 78
Gluten Free Adults 18–50 Dairy Free
Report overview
B+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value
Each serving provides 729 mg of EPA at a low cost per gram of EPA. The EPA is in triglyceride form. The oil is described as purified, but specific contaminant testing is not indicated.
How this ingredient is rated

Active Ingredient Quality & Bioavailability83

The EPA is in triglyceride form. EPA makes up about 55% of the fish oil.
Molecular Form and Bioavailability
The EPA is in triglyceride form.
EPA Concentration Density
EPA makes up about 55% of the fish oil.
Oxidation Protection
Tocopherol is included, though actual protection from oxidation is not established.

Dose, Safety & Label Transparency82

Each serving provides 729 mg of EPA and 275 mg of DHA. The oil is described as purified, but specific contaminant testing is not indicated.
Absolute EPA Dose per Serving
Each serving provides 729 mg of EPA.
EPA-Centric Ratio
The serving contains 275 mg of DHA, less than the EPA amount.
Purity and Contaminant Testing
The oil is described as purified, but specific contaminant testing is not indicated.

Value100

The cost per gram of EPA is low.
Price per Gram of EPA
The cost per gram of EPA is low.
Fish Oil · 1326 mg OverallScore87
B- Active Ingredient Quality & BioavailabilityA Dose, Safety & Label TransparencyA+ Value
Each serving provides 1004 mg combined EPA and DHA at a low cost per gram. A triglyceride form is indicated. A purification method is claimed.
How this ingredient is rated

Active Ingredient Quality & Bioavailability74

A triglyceride form is indicated. A specific purification method is claimed, but its name is unclear. No independent testing claim is indicated.
Omega-3 Molecular Form
A triglyceride form is indicated.
Purification & Filtration Method
A specific purification method is claimed, but its name is unclear.
Third-Party Purity & Potency Verification
No independent testing claim is indicated.
Source & Sustainability
Alaska pollock is listed in Other Ingredients; its relationship to the fish oil amount is unclear.

Dose, Safety & Label Transparency94

A serving provides 729 mg EPA and 275 mg DHA, for 1004 mg combined. EPA and DHA make up about 76% of the 1326 mg fish oil serving. An antioxidant stabilizer is indicated, but its identity is unclear.
Total Active Omega-3 Dose (EPA + DHA)
A serving provides 729 mg EPA and 275 mg DHA, for 1004 mg combined.
Omega-3 Potency & Concentration
EPA and DHA make up about 76% of the 1326 mg fish oil serving.
EPA & DHA Individual Disclosure
EPA and DHA are listed separately at 729 mg and 275 mg per serving, respectively.
Oxidation Protection (Stabilizers)
An antioxidant stabilizer is indicated, but its identity is unclear.

Value100

The cost per gram of EPA and DHA is low.
Cost Per Gram of Active EPA + DHA
The cost per gram of EPA and DHA is low.
Omega-3 · 1100 mg OverallScore78
B- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value
A serving provides 1004 mg of EPA and DHA at a low cost per gram. EPA and DHA make up about 76% of the oil. The omega-3s are in triglyceride form.
How this ingredient is rated

Active Ingredient Quality & Bioavailability72

The omega-3s are in triglyceride form. The product contains fish oil; the available information does not indicate an antioxidant, so oxidation protection is unclear.
Molecular Form & Absorption Potential
The omega-3s are in triglyceride form.
Source Purity & Oxidative Protection
The product contains fish oil; the available information does not indicate an antioxidant, so oxidation protection is unclear.

Dose, Safety & Label Transparency73

The label lists 729 mg EPA and 275 mg DHA per serving. EPA and DHA make up about 76% of the 1326 mg of oil per serving.
EPA & DHA Label Specificity
The label lists 729 mg EPA and 275 mg DHA per serving.
Active Ingredient Concentration
EPA and DHA make up about 76% of the 1326 mg of oil per serving.
Third-Party Purity Verification
Testing is claimed, but an available certificate of analysis or qualifying product seal is not established.

Value100

The cost per gram of EPA and DHA is low.
Price per 1000mg of EPA+DHA
The cost per gram of EPA and DHA is low.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  2. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  3. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  4. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  5. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  6. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  7. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  8. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  9. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsEye Health forEPA (Eicosapentaenoic Acid)
  10. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  11. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  12. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsInflammation forFish Oil
  17. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsInflammation forFish Oil
  18. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsInflammation forFish Oil
  19. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsInflammation forFish Oil
  20. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledInflammation forFish Oil